Alira Health

Alira Health is an international advisory firm that specializes in providing integrated transaction advisory, management consulting, medical affairs advisory, and innovative research services for healthcare and life science companies. Founded in 1999 and headquartered in the United States, Alira Health collaborates with strategists, bankers, doctors, and scientists to deliver comprehensive insights across various facets of healthcare. The firm assists multinational corporations, institutional investors, creditors, and governments in activities such as company sales, acquisitions, strategic partnerships, and financial restructurings, aiming to enhance the efficiency and effectiveness of funding and operational strategies worldwide.

Gabriele Brambilla

Co-Owner and Co-CEO

Jean-Louis Simon

Partner

10 past transactions

Artisan Healthcare Consulting

Acquisition in 2022
Artisan Healthcare Consulting is a management consulting firm that specializes in providing strategic and quantitative analysis for healthcare companies. The firm focuses on enhancing market growth through tailored business development and branding strategies. Its services include consultancy on brand strategy, analytics, emerging biopharma, global market access, primary market research, and supply chain strategy. By offering these comprehensive solutions, Artisan Healthcare Consulting aims to assist healthcare companies in navigating complex market dynamics and achieving sustainable growth.

Sourcia

Acquisition in 2022
Sourcia specializes in clinical trial services, catering specifically to small-to-medium-sized biotechnology and medical device companies in Europe. The company supports all phases of clinical trials, from Phase I to Phase IV, and is involved in both pre- and post-CE marking activities. In addition to clinical trials, Sourcia provides consulting services focused on drug development and the creation of new medical therapies, helping clients navigate the complexities of medical innovation and growth.

Self Care Catalysts

Acquisition in 2022
Self Care Catalysts is a company focused on empowering patients by providing valuable insights and data through its cloud-based digital therapeutics and self-care platform. The platform facilitates patient-centered clinical trials, enhances patient engagement, and supports behavior intervention programs, while offering analytics that benefit patients, healthcare providers, and pharmaceutical companies. By consolidating health storylines, Self Care Catalysts aims to enable users to make informed decisions to improve health outcomes. The company operates from its offices in the MaRS Discovery District in Toronto, Canada, and San Francisco, California, and is backed by a range of partners including Springboard Enterprises and the Rick Hansen Institute.

PatchAi

Acquisition in 2021
PatchAi Srl is an innovative start-up focused on enhancing late-phase and real-world studies through patient-centric approaches and advanced digital technologies, including artificial intelligence and machine learning. The company's primary offering is PatchAi, a cognitive platform designed to support patients participating in clinical trials. This platform features an empathic virtual assistant that interprets patients' needs and implements tailored strategies to foster engagement. It collects vital data on symptoms, adverse events, therapy adherence, and quality of life. By integrating insights from various data sources, PatchAi aims to revolutionize data collection and improve the efficiency and safety of medical product development, ultimately benefiting patient outcomes.

Be Patient

Acquisition in 2021
Be Patient provides e-Health solutions for human care.

CROS NT

Acquisition in 2021
CROS NT is a provider of innovative biometrics solutions focused on enhancing the development of therapeutics for patients. The company specializes in data-driven services that include digital technologies, data integration, standardization, visualization, and analytics. By leveraging its expertise in clinical data management, biostatistics, and statistical programming, CROS NT aims to support clients in achieving improved insights and outcomes while reducing risks in their projects. Through its tailored approach, the company is committed to making the therapeutic development process more efficient and affordable.

X-COR Therapeutics

Seed Round in 2020
X-COR Therapeutics is a medical device company based in Allston, Massachusetts, founded in 2017. The company specializes in developing a novel CO2 removal device designed to treat patients experiencing acute respiratory failure. Its innovative system utilizes a hybrid approach, allowing for the extraction of excess CO2 from the blood through small catheters at ultra-low blood flows of less than 300 ml/min, which can be managed by nursing staff. This method offers a safer, more affordable, and more accessible treatment option compared to traditional extracorporeal devices that typically require higher blood flows and specialized physician intervention. X-COR's technology includes a patent-pending medical device and a machine-learning-based control algorithm, facilitating compatibility with existing medical infrastructure for ease of deployment. The company gained recognition as a runner-up in the 2018 Harvard President’s Innovation Challenge and participated in the MedTech Innovator and MassChallenge cohorts that same year.

Wellmera

Acquisition in 2019
Wellmera AG is an independent consulting company based in Basel, Switzerland, founded in 2011. It specializes in providing market access, pricing, health economics and outcomes research (HEOR), and commercial expertise to pharmaceutical and biotechnology companies. Wellmera assists its clients in demonstrating the value of their products, optimizing patient access, and capitalizing on commercial opportunities. As of December 2019, Wellmera operates as a subsidiary of CMC Consulting Boston Inc.

Clinical Insights

Acquisition in 2018
Clinical Insights Limited is a data analytics company that specializes in providing predictive analysis and business advisory services to healthcare and pharmaceutical companies. Founded in 2012 and headquartered in Milan, Italy, the company aims to enhance business performance by utilizing dynamic analytical techniques and real-time market information. Its solutions allow clients to optimize performance, refine market insights, and develop effective business strategies based on sophisticated analyses of big data. Clinical Insights helps clients identify hidden product flows, smooth out demand volatility, and adapt quickly to market changes, thereby minimizing the risk of losing market share. The company's offerings also include tools for real-time market feedback and supply chain information, allowing clients to make informed and timely decisions to improve their overall management and business outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.